Psychiatry And Business Collaborate: European Psychedelics Trial Tackles Alcohol Addiction
Clinical-stage natural psychedelics developer Filament Health (OTCQB: FLHLF) and the Psychiatric Center Copenhagen’s collaborative clinical trial has been approved by the Danish Medicines Agency and is set to commence this February.
